SubsidieMeestersAdvanced imaging system for Medical Applications
The i-TED project aims to demonstrate the applicability of a gamma-ray imaging system in intraoperative Radio-Guided Surgery and neutron dose assessment in boron-neutron capture therapy.
Projectdetails
Introduction
i-TED is a gamma-ray imaging system that was fully developed and successfully applied for nuclear astrophysics experiments at CERN n_TOF in the previous HYMNS ERC CoG.
System Characteristics
i-TED was designed for the highest possible detection sensitivity, and it is also characterized by its modularity, portability, and low sensitivity to neutron-induced backgrounds.
These characteristics make the developed system potentially very attractive for several emerging applications in health and life science.
Potential Applications
Indeed, Compton imagers are expected to provide a breakthrough innovation potential in the fields of:
- Ion-range monitoring in hadron therapy
- Intraoperative Radio-Guided Surgery (RGS)
- Dose-monitoring in boron-neutron capture therapy (BNCT)
- Theranostics (radioisotopes that serve for both therapy and diagnostics)
Project Aim
Thus, the aim of this POC proposal is to perform first proof-of-concept measurements with readily available i-TED Compton cameras for demonstrating their applicability and advantages in two of these fields:
- Intraoperative RGS
- Neutron dose assessment in BNCT
Technical Readiness Levels
We also aim at addressing the corresponding technical-readiness levels (TRLs) for each application, which seems the most convenient approach for an efficient transfer of the developed technology towards society.
Financiële details & Tijdlijn
Financiële details
| Subsidiebedrag | € 150.000 |
| Totale projectbegroting | € 150.000 |
Tijdlijn
| Startdatum | 1-11-2023 |
| Einddatum | 31-12-2025 |
| Subsidiejaar | 2023 |
Partners & Locaties
Projectpartners
- AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICASpenvoerder
- UNIVERSIDAD DE GRANADA
- AIMPLAS - ASOCIACION DE INVESTIGACION DE MATERIALES PLASTICOS Y CONEXAS
Land(en)
Vergelijkbare projecten binnen European Research Council
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Prompt Gamma Time Imaging: a new medical-imaging modality for adaptive Particle TherapyThe project aims to enhance particle therapy efficacy and safety by developing Prompt Gamma Time Imaging for real-time monitoring of treatment, improving dose control and adaptive dosimetry. | ERC Starting... | € 1.498.969 | 2022 | Details |
3D silicon detector for imaging of diagnostic and therapeutic nuclear medicine radiotracers with outstanding efficiency and high spatial resolution.This project aims to develop a novel molecular imaging instrument using advanced silicon sensors to enhance efficiency and resolution, potentially revolutionizing medical imaging and related research fields. | ERC Advanced... | € 3.351.875 | 2024 | Details |
Gamma-Neutron Vision aimed at improved cancer treatments in Hadron TherapyThis project aims to develop a portable device for simultaneous gamma-ray and thermal neutron imaging to enhance ion-range verification and secondary neutron dose assessment in proton therapy. | ERC Proof of... | € 150.000 | 2024 | Details |
Open Geometry PET, with 150ps TOF Resolution, for Real Time Molecular ImagingOpen-IMAGING aims to create a flexible Open Imaging System using advanced PET technology for high-resolution imaging, enabling safer interventions and improved patient monitoring. | ERC Proof of... | € 150.000 | 2022 | Details |
Towards pediatric molecular imaging: development of a low-dose and high-performance Total Body PET scannerDeveloping the PHOENIX total body PET scanner aims to enhance pediatric imaging by achieving high sensitivity and spatial resolution while ensuring patient safety and comfort. | ERC Starting... | € 1.464.841 | 2024 | Details |
Prompt Gamma Time Imaging: a new medical-imaging modality for adaptive Particle Therapy
The project aims to enhance particle therapy efficacy and safety by developing Prompt Gamma Time Imaging for real-time monitoring of treatment, improving dose control and adaptive dosimetry.
3D silicon detector for imaging of diagnostic and therapeutic nuclear medicine radiotracers with outstanding efficiency and high spatial resolution.
This project aims to develop a novel molecular imaging instrument using advanced silicon sensors to enhance efficiency and resolution, potentially revolutionizing medical imaging and related research fields.
Gamma-Neutron Vision aimed at improved cancer treatments in Hadron Therapy
This project aims to develop a portable device for simultaneous gamma-ray and thermal neutron imaging to enhance ion-range verification and secondary neutron dose assessment in proton therapy.
Open Geometry PET, with 150ps TOF Resolution, for Real Time Molecular Imaging
Open-IMAGING aims to create a flexible Open Imaging System using advanced PET technology for high-resolution imaging, enabling safer interventions and improved patient monitoring.
Towards pediatric molecular imaging: development of a low-dose and high-performance Total Body PET scanner
Developing the PHOENIX total body PET scanner aims to enhance pediatric imaging by achieving high sensitivity and spatial resolution while ensuring patient safety and comfort.
Vergelijkbare projecten uit andere regelingen
| Project | Regeling | Bedrag | Jaar | Actie |
|---|---|---|---|---|
Non-ionizing Metabolic Imaging for predicting the effect of and guiding Therapeutic InterventionsMITI aims to develop advanced non-invasive metabolic imaging technology for early disease detection and therapy effectiveness assessment, improving patient outcomes and reducing healthcare costs. | EIC Transition | € 2.100.238 | 2022 | Details |
REAL TIME MOLECULAR IMAGER WITH UNSURPASSED RESOLUTIONRETIMAGER aims to revolutionize PET imaging by achieving ten-fold improvements in spatial and temporal resolution, enabling real-time, high-sensitivity imaging for personalized precision medicine. | EIC Pathfinder | € 3.126.347 | 2023 | Details |
Next generation Limited-Angle time-of-flight PET imagerThe PetVision project aims to develop a cost-effective, modular PET imaging device with enhanced sensitivity to improve cancer diagnostics accessibility across various medical settings. | EIC Pathfinder | € 3.374.041 | 2023 | Details |
Fast gated superconducting nanowire camera for multi-functional optical tomographThis project aims to develop a multifunctional optical tomograph using an innovative light sensor to enhance deep body imaging and monitor organ functionality with 100x improved signal-to-noise ratio. | EIC Pathfinder | € 2.495.508 | 2023 | Details |
2D Material-Based Multiple Oncotherapy Against Metastatic Disease Using a Radically New Computed Tomography ApproachPERSEUS aims to develop a novel nanotechnology-based cancer therapy that activates under CT imaging to treat deep-seated, drug-resistant tumors with minimal side effects. | EIC Pathfinder | € 2.740.675 | 2023 | Details |
Non-ionizing Metabolic Imaging for predicting the effect of and guiding Therapeutic Interventions
MITI aims to develop advanced non-invasive metabolic imaging technology for early disease detection and therapy effectiveness assessment, improving patient outcomes and reducing healthcare costs.
REAL TIME MOLECULAR IMAGER WITH UNSURPASSED RESOLUTION
RETIMAGER aims to revolutionize PET imaging by achieving ten-fold improvements in spatial and temporal resolution, enabling real-time, high-sensitivity imaging for personalized precision medicine.
Next generation Limited-Angle time-of-flight PET imager
The PetVision project aims to develop a cost-effective, modular PET imaging device with enhanced sensitivity to improve cancer diagnostics accessibility across various medical settings.
Fast gated superconducting nanowire camera for multi-functional optical tomograph
This project aims to develop a multifunctional optical tomograph using an innovative light sensor to enhance deep body imaging and monitor organ functionality with 100x improved signal-to-noise ratio.
2D Material-Based Multiple Oncotherapy Against Metastatic Disease Using a Radically New Computed Tomography Approach
PERSEUS aims to develop a novel nanotechnology-based cancer therapy that activates under CT imaging to treat deep-seated, drug-resistant tumors with minimal side effects.